Vector Immunogenicity

Vector immunogenicity is the inherent capacity of a gene therapy vector to provoke an immune response in the host organism, distinguishing it from other vector properties by its specific role in activating innate and adaptive immune pathways against the delivered genetic construct.

195

Publications

13.4K

Citations

1.6K

Authors

428

Institutions

Publications per year

2017–2026

44

Publications

195

Authors

1.6K

  1. DC
    David C. Montefiori

    Duke Medical Center, United States

    6 publications · 334 citations

    6

    h-index

  2. GD
    Georgia D. Tomaras

    Duke University, United States

    5 publications · 302 citations

    5

    h-index

  3. BM
    Bernard Moss

    National Institute of Allergy and Infectious Diseases, United States

    5 publications · 726 citations

    5

    h-index

  4. KA
    Katherine A. High

    Children's Hospital of Philadelphia, United States

    5 publications · 653 citations

    5

    h-index

  5. DH
    Dan H. Barouch

    Beth Israel Deaconess Medical Center, United States

    5 publications · 764 citations

    5

    h-index

1–5 of 1.6K

Venues

  1. Journal of Virology

    JVI · 24 publications · 2.5K citations

    22

    h-index

  2. Molecular Therapy

    14 publications · 972 citations

    14

    h-index

  3. Vaccine

    15 publications · 789 citations

    14

    h-index

  4. PLoS ONE

    11 publications · 830 citations

    10

    h-index

  5. Gene Therapy

    10 publications · 928 citations

    10

    h-index

1–5